Syngene International Ltd

BSE: 539268

17

total announcements

539268.BO · 15 min delayed

BSEAGM/EGMResults31 Jul 2026

Syngene International Ltd

Scrutinizer''s Report and voting results of 33rd Annual General Meeting

Syngene International Ltd's 33rd Annual General Meeting (AGM) voting results and Scrutinizer's Report have been submitted. All 9 resolutions were approved with the requisite majority by the shareholders. The details of votes cast by shareholders are given in the attached Annexure A. The results of e-voting along with Scrutinizer's Report are also available on the Company's website and on the website of Kfin Technologies Limited, the Register and Share Transfer Agents.

Read more →📎 1 attachment
BSECompany UpdateResults30 Jul 2026

Syngene International Ltd

Newspaper Advertisement - Financial Results

Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue at ₹7,360 crore, profit before tax at ₹4,875 crore, and profit after tax at ₹1,013 crore.

Read more →📎 1 attachment
BSECompany UpdateResults29 Jul 2026

Syngene International Ltd

Investor Presentation

Syngene International Ltd has released an investor presentation for Q1 FY27, highlighting a 16% Y-o-Y decline in revenue from operations to Rs 736 Cr, with EBITDA margin at 12% (24% in Q1 FY26). The company has strengthened its AI-enabled scientific platform, Syngene's AI-enabled scientific platform for accelerating drug discovery services, and has been recognized as one of the world's top 750 most sustainable companies for the second consecutive year.

Read more →📎 1 attachment
BSEAGM/EGMResults29 Jul 2026

Syngene International Ltd

Proceedings of the 33rd Annual General Meeting

Syngene International Ltd held its 33rd Annual General Meeting on July 29, 2026, through video conferencing, where 117 members were present. The meeting approved the audited financial statements for the year ended March 31, 2026, and declared a final dividend of Rs. 1.25 per equity share.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change29 Jul 2026

Syngene International Ltd

Resignation of Independent Director

Syngene International Ltd announced the resignation of Independent Director Mr. Kush Parmar, effective July 29, 2026, due to increasing commitments in the USA and inability to devote sufficient time to the Company.

Read more →📎 1 attachment
BSECompany Update▼ NegativeResults29 Jul 2026

Syngene International Ltd

Press Release

Syngene International Limited announced its Q1 FY27 results, with revenue from operations at Rs. 736 Cr and operating EBITDA at Rs. 91 Cr. The company's performance was impacted by the lack of offtake from a major biologics client and forex hedge loss. Despite this, the company maintains a strong balance sheet and financial discipline, which provides flexibility to invest in strategic priorities.

Read more →📎 1 attachment
BSEResult▼ NegativeResults29 Jul 2026

Syngene International Ltd

Results - Financial Results for quarter ended June 30, 2026

Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a profit before tax of Rs. (192) million and a profit for the period of Rs. (90) million. The results also include a net loss of Rs. (135) million from exceptional items.

Read more →📎 1 attachment
BSEBoard MeetingResults29 Jul 2026

Syngene International Ltd

Outcome of the Board Meeting held on July 29, 2026

Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 6,630 million and a net profit of Rs. 21 million. The company's consolidated revenue from operations was Rs. 7,360 million, with a net profit of Rs. 90 million.

Read more →📎 1 attachment